Delivery Order SPE2DB22D3010-SPE2DB26FP0RB
Award Date 10/15/25
Potential Completion Date 10/16/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,803.07 on September 15, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count). This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $8,794.31 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract. This non-set-aside award was executed on August 10, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $10,411.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120-count supply) on September 18, 2025, with a ceiling value of $8,208.17 and an ultimate completion date of September 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $12,789.51 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a $3,539.98 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,781.36 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count packages) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,334.85 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $32.9K. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location and scheduled for completion by September 29, 2025. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) under a firm fixed-price contract valued at $3,925.16. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a continuation of the company's role...